Introduction {#sec1-1}
============

Systemic retinoids such as isotretinoin and acitretin are essential for dermatological therapy but are associated with numerous side effects. Isotretinoin induces thinning of the skin.\[[@ref1]\] It also decreases collagenase action and enhances hypertrophic or keloidal scarring following mechanical dermabrasion surgery and ablative laser treatment performed during, immediately after, and before isotretinoin treatment.\[[@ref1][@ref2][@ref3]\] Findings in the literature concerning the adverse effects of systemic isotretinoin on wound healing are reported to be inconsistent.\[[@ref1]\] Isotretinoin, when used in therapeutic dosages (≤2 mg/kg/d), does not seem to impair wound healing.\[[@ref1]\] Moreover, the optimal timing for surgery in patients taking systemic isotretinoin remains unclear.\[[@ref1]\] A comprehensive review of isotretinoin treatment and concurrent surgical procedures was inconclusive in this context.\[[@ref2]\] Another consensus report concluded that there is insufficient evidence to recommend delaying cutaneous surgery not involving muscles in patients on isotretinoin treatment or in those who recently completed such treatment.\[[@ref3]\] Another study reported that it is doubtful that isotretinoin can affect wound healing negatively, but there is a small risk that it may.\[[@ref2]\] Surgical outcome in patients taking isotretinoin during the perioperative period was reported to be no different than in those not taking isotretinoin.\[[@ref4]\] A study on organ transplant recipients undergoing surgical treatment for skin cancers reported there were no differences in wound-healing complications between those taking and not taking acitretin chemoprophylaxis;\[[@ref5]\] however, only one study examined the outcome of previous surgical procedures during subsequent retinoid treatment.\[[@ref6]\] Herein, we describe two cases of scar dehiscence that developed after initiation of systemic retinoid treatment following cutaneous surgery.

Case Reports {#sec1-2}
============

 {#sec2-1}

### Case 1 {#sec3-1}

An otherwise healthy 17-year-old male undergone excision of an inflamed sebaceous cyst located on his right cheek. The patient presented again with nodulocystic acne and began treatment with oral isotretinoin 1 mg/kg/d. On day 29 of the treatment, he hit his right cheek and the incision scar (approximately 130 day old) was dehisced \[[Figure 1](#F1){ref-type="fig"}\]. It was followed by local wound dressings while continuing oral isotretinoin treatment. The wound healed by secondary intention in about 2.5 months, leaving an atrophic depressed scar \[[Figure 2](#F2){ref-type="fig"}\].

![Scar dehiscence on the right cheek in Case 1 on day 29 of isotretinoin treatment](IJD-64-68-g001){#F1}

![In Case 1, the wound healed through secondary intention in about 2.5 months, leaving an atrophic scar on the right cheek](IJD-64-68-g002){#F2}

### Case 2 {#sec3-2}

An 81-year-old male was operated for squamous cell carcinoma (SCC) located on the left ear helical border. A new tumoral nodule was detected on the right side of the midline of the forehead and excised 40 day later, and the histopathological diagnosis was again well-differentiated SCC. Oral acitretin 25 mg/d was initiated for chemoprevention of new SCC and treatment of widespread actinic keratoses. On day 8 of treatment, the surgical scar on the patient\'s forehead (25 day old) was dehisced. During the next few days, the left helical scar widened. Scar dehiscence on the forehead healed in about 7 weeks via secondary intention with wound dressings.

Discussion {#sec1-3}
==========

The literature includes only three patients reported to have developed complications of surgical procedures that occurred during or subsequent use of isotretinoin.\[[@ref6]\] All three of these patients underwent septorhinoplasty before starting oral isotretinoin treatment in the previous 2 years and all developed nasal tip deformities within 6 months of the initiation of isotretinoin treatment. Authors concluded that nasal tip deformity had developed due to isotretinoin\'s creation of imbalance between collagen production and degradation, as well as the accentuated "shrink and wrap" phenomenon associated with the abnormally thin nasal epidermis, and recommended postponing isotretinoin treatment for a minimum of 2 years following rhinoplasty;\[[@ref6]\] however, Cobo and Vitery\[[@ref7]\] reported that concomitant initiation of isotretinoin treatment with rhinoplasty helped to define the nasal tip and improved the surgical outcome in thick-skinned patients.

Shigematsu and Tajima\[[@ref8]\] reported that 13-cis-retinoic acid and etretinate inhibited collagen and noncollagenous protein synthesis in fibroblast cell cultures, although 13-cis-retinoic acid did so to a greater degree (66% reduction in collagen synthesis). Etretinate, but not 13-cis-retinoic acid, was reported to inhibit DNA synthesis (by 45%), and therefore, inhibited fibroblast proliferation; the researchers concluded that 13-cis-retinoic acid was the more valuable compound for the treatment of fibrotic disorders.\[[@ref8]\] Ohta *et al*.\[[@ref9]\] noted that all-trans-retinal (vitamin A aldehyde) (final collagenase activity was 14.3% of control) and all-trans-retinoic acid (final collagenase activity was 39.4% of control) were potent inhibitors of collagenase (MMP-1) production, but that 13-cis-retinoic acid (final collagenase activity was 57.7% of control) inhibited collagenase production to a lesser extent in human mononuclear cells in culture.

In Case 1, isotretinoin was thought to decrease collagen synthesis to a greater degree than collagen degradation during the postoperative wound remodeling phase. Due to this decrease in collagen synthesis, the patient\'s scar contained less collagen than normal scar at that age and was therefore weak, and dehiscence occurred following subsequent minor trauma. In Case 2, acitretin was started during the proliferation phase of wound healing. As acitretin inhibited both fibroblast proliferation and collagen synthesis, the patient\'s surgical wound was thought to get less cellular, with a decrease in collagen content and wound strength than normal scar at that age. Subsequently, the patient\'s scar dehisced spontaneously. The helical scar in Case 2 was older than that in Case 1 and was enlarged due to a decrease in collagen synthesis during the 3^rd^ month of the wound remodeling phase. Since acitretin impaired collagen synthesis to a lesser degree in comparison with isotretinoin, it was thought that dehiscence was not observed in helical scar of Case 2. Acitretin was reported to delay secondary wound healing in rats.\[[@ref10]\] Both of the presented cases experienced delayed secondary wound healing of dehisced scars while treatment with systemic retinoids was ongoing. Case 2 had an uneventful recovery following abdominal surgery and his third skin cancer excision.

Based on our experience with the presented cases, it is recommended that it may be beneficial to postpone systemic retinoid treatment for 6 months to 1 year following cutaneous surgery, located especially in cosmetically important sites. We concluded so because the remodeling phase of the wound healing process was generally completed in 1 year. Wound tensile strength is also related to this phase of wound healing and the maximum tensile strength of the wound is achieved in 3--6 months following creation of a wound.
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